Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angelo Castello

Showing results (21-30 of 80) with videos related to

Pageof 8
Sort By:
Biomedicines|October 26, 2024
Prognostic Role of PSMA-Targeted Imaging in Metastatic Castration-Resistant Prostate Cancer: An OverviewMatteo Caracciolo, Angelo Castello, Massimo Castellani, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 22, 2019
Hyperprogressive Disease in Patients with Non-Small Cell Lung Cancer Treated with Checkpoint Inhibitors: The Role of <sup>18</sup>F-FDG PET/CTAngelo Castello, Sabrina Rossi, Emanuela Mazziotti, et al.
Nuclear Medicine Communications|May 7, 2020
The role of 11C-methionine PET in patients with negative diffusion-weighted magnetic resonance imaging: correlation with histology and molecular biomarkers in operated gliomasAngelo Castello, Marco Riva, Bethania Fernandes, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 23, 2018
Prostate-specific antigen flare induced by <sup>223</sup>RaCl<sub>2</sub> in patients with metastatic castration-resistant prostate cancerAngelo Castello, H A Macapinlac, E Lopci, et al.
Molecular Imaging and Biology|July 14, 2018
The Complexity and Fractal Geometry of Nuclear Medicine ImagesFabio Grizzi, Angelo Castello, Dorina Qehajaj, et al.
Journal of Cancer Research and Clinical Oncology|February 13, 2020
The immune-metabolic-prognostic index and clinical outcomes in patients with non-small cell lung carcinoma under checkpoint inhibitorsAngelo Castello, Luca Toschi, Sabrina Rossi, et al.
Clinical Nuclear Medicine|September 10, 2021
An Incidental Uptake of 18F-Choline in ParagangliomaAngelo Castello, Giulia Zuccotti, Elena Bonatto, et al.
Clinical Nuclear Medicine|September 13, 2023
Brain 18 F-FET in a Case of Acute Myeloid LeukemiaAngelo Castello, Giacomo Crosta, Sara Pacella, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|May 21, 2026
Imaging ImmunotherapyEgesta Lopci, Angelo Castello, Matteo Caracciolo, et al.
Molecular Imaging and Biology|March 25, 2020
Metabolic Switch in Hepatocellular Carcinoma Patients Treated with Sorafenib: a Proof-of-Concept TrialAngelo Castello, Lorenza Rimassa, Nicola Personeni, et al.
Pageof 8

Showing results (21-30 of 80) with videos related to

Sort By:
Pageof 8
Biomedicines|October 26, 2024
Prognostic Role of PSMA-Targeted Imaging in Metastatic Castration-Resistant Prostate Cancer: An OverviewMatteo Caracciolo, Angelo Castello, Massimo Castellani, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 22, 2019
Hyperprogressive Disease in Patients with Non-Small Cell Lung Cancer Treated with Checkpoint Inhibitors: The Role of <sup>18</sup>F-FDG PET/CTAngelo Castello, Sabrina Rossi, Emanuela Mazziotti, et al.
Nuclear Medicine Communications|May 7, 2020
The role of 11C-methionine PET in patients with negative diffusion-weighted magnetic resonance imaging: correlation with histology and molecular biomarkers in operated gliomasAngelo Castello, Marco Riva, Bethania Fernandes, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 23, 2018
Prostate-specific antigen flare induced by <sup>223</sup>RaCl<sub>2</sub> in patients with metastatic castration-resistant prostate cancerAngelo Castello, H A Macapinlac, E Lopci, et al.
Molecular Imaging and Biology|July 14, 2018
The Complexity and Fractal Geometry of Nuclear Medicine ImagesFabio Grizzi, Angelo Castello, Dorina Qehajaj, et al.
Journal of Cancer Research and Clinical Oncology|February 13, 2020
The immune-metabolic-prognostic index and clinical outcomes in patients with non-small cell lung carcinoma under checkpoint inhibitorsAngelo Castello, Luca Toschi, Sabrina Rossi, et al.
Clinical Nuclear Medicine|September 10, 2021
An Incidental Uptake of 18F-Choline in ParagangliomaAngelo Castello, Giulia Zuccotti, Elena Bonatto, et al.
Clinical Nuclear Medicine|September 13, 2023
Brain 18 F-FET in a Case of Acute Myeloid LeukemiaAngelo Castello, Giacomo Crosta, Sara Pacella, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|May 21, 2026
Imaging ImmunotherapyEgesta Lopci, Angelo Castello, Matteo Caracciolo, et al.
Molecular Imaging and Biology|March 25, 2020
Metabolic Switch in Hepatocellular Carcinoma Patients Treated with Sorafenib: a Proof-of-Concept TrialAngelo Castello, Lorenza Rimassa, Nicola Personeni, et al.
Pageof 8